Inventor · disambiguated record
Murali Krishna Addepalli
Also filed as: ADDEPALLI MURALI · ADDEPALLI MURALI KRISHNA
5 granted patents·2 pending applications·17 citations·filing 2007–2020
75Inventor score
Top patents by PatentIndex Score
7 records- 0188US10010587B2IL-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibodyNEKTAR THERAPEUTICS·Filed 2015·Granted Jul 3, 2018·11 cites·15 claims
- 0276US10786552B2Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibodyNEKTAR THERAPEUTICS·Filed 2018·Granted Sep 29, 2020·1 cites·18 claims
- 0373US8026225B2Short nucleic acid molecule-mediated modulation of Aurora B kinase expression and combinations for use in anticancer therapyRELIANCE LIFE SCIENCES PVT LTD·Filed 2009·Granted Sep 27, 2011·3 cites·24 claims
- 0469US7615627B2RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapyRELIANCE LIFE SCIENCES PVT LTD·Filed 2007·Granted Nov 10, 2009·1 cites·10 claims
- 0562US2020368321A1Il-2rbeta-selective agonists in combination with an anti-ctla-4 antibody or an anti-pd-1 antibodyNEKTAR THERAPEUTICS·Filed 2020·Application pending·0 cites
- 0651US8188264B2RNAi mediated knockdown of NuMA for cancer therapyADDEPALLI MURALI·Filed 2010·Granted May 29, 2012·1 cites·5 claims
- 0748US2009054366A1RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPYRELIANCE LIFE SCIENCES PVT LTD·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Murali Krishna Addepalli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →